News
Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...
Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results